´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ Á¦133Â÷ Ãá°èÇмú´ëȸ : 2022-04-16±³À°ÀÏÀÚ : 2022-04-16
±³À°Àå¼Ò : °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ(HICO)
±³À°ÁÖÁ¦ :
Á¦133Â÷ Ãá°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ
´ã´çÀÚ : ±è¹Ì¼±
¿¬¶ôó : 02-575-3825
À̸ÞÀÏ :
katrd@hanmail.net ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 600¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
°æ»óºÏµµ±³À°½Ã°£ : 4 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 70,000¿ø
ºñ°í »çÀüµî·Ï : Àü¹®ÀÇ, ÀϹÝÀÇ 60,000¿ø / Àü°øÀÇ, ±âŸ 40,000¿ø ÇöÀåµî·Ï : Àü¹®ÀÇ, ÀϹÝÀÇ 70,000 / Àü°øÀÇ, ±âŸ 50,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-16 3F 12:00~12:50 ¡°The effectiveness of Triple therapy in RCT and real world evidence in patients with COPD¡± ¹Ú¿ë¹ü(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 04-16 3F 13:40~14:30 ¡°Aerosol & Phage Therapy for MDR Respiratory Pathogen¡± ÀåÀ±°æ(The University of Sydney)
±³À°½Ã°£ 04-16 3F 14:50~15:40 ARDS: Which Rescue Firstly in ARDS, Prone Positioning vs. ECMO? Á¤°æ¼ö ±è¿ø¿µ Á¶¿µÀç(¿¬¼¼ÀÇ´ë Áß¾ÓÀÇ´ë ¼¿ïÀÇ´ë)
±³À°½Ã°£ 04-16 3F 15:40~16:30 Session ¥± ÁÂÀå : ÀåÁßÇö Asthma Management: Track 1. ICS-formoterol vs. Track 2. ICS+non-formoterol SABA ±èâȯ ÀåÁ¾°É(Á¦ÁÖÀÇ´ë ¿µ³²ÀÇ´ë)
±³À°½Ã°£ 04-16 3F 16:50~17:40 Inhaled Conventional Amikacin for NTM Àüº´¿ì Á¶°æ¿í(¼º±Õ°üÀÇ´ë ¿ï»êÀÇ´ë)
Åä·Ð 04-16 3F 17:40~18:00 ÇмúÄûÁî ½Å°æö(¿µ³²ÀÇ´ë)